Anghel Adrian U.
- Country
- Romania
- Department
- Oncologie medicala
Research Overview
- Comparative Study of JPB898 and Nivolumab in Combination with Ipilimumab for Advanced Unresectable/Metastatic Melanoma
- Efficacy, Safety, and Immunogenicity Comparison of GME751 Versus EU-Authorized Pembrolizumab in Treatment-Naïve Metastatic Non-Small-Cell Lung Cancer Patients
- Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Data & Insights
Has run more than one trial at 484 of 794 partner sites.
Specializations
Lung Cancer Research
Specializes in investigating treatments for various forms of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), including both early-stage and advanced disease states.
- Advanced and metastatic NSCLC therapies
- EGFR Exon 20 insertion mutations
- KRAS G12C mutation treatments
- SCLC with SLFN11 expression
Breast Cancer Studies
Focuses on developing treatments for various breast cancer subtypes, including HER2-positive breast cancer, triple-negative breast cancer, and hormone receptor-positive cases.
- Early-stage breast cancer treatments
- Metastatic breast cancer therapies
- ER+/HER2- breast cancer interventions
Gastrointestinal Oncology
Investigates treatments for gastric cancer, gastroesophageal junction adenocarcinoma, and related gastrointestinal malignancies.
- HER2-positive gastric cancer treatments
- Advanced gastroesophageal therapies
- Neuroendocrine tumor management
Head and Neck Cancer
Studies treatments for squamous cell carcinoma of the head and neck, including recurrent and metastatic disease.
- HPV-negative HNSCC treatments
- Recurrent/metastatic disease management
- Novel combination therapies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
